Authors:
Nezu, JI
Tamai, I
Oku, A
Ohashi, R
Yabuuchi, H
Hashimoto, N
Nikaido, H
Sai, A
Koizumi, K
Shoji, Y
Takada, G
Matsuishi, T
Yoshino, M
Kato, H
Ohura, T
Tsujimoto, G
Hayakawa, J
Shimane, M
Tsuji, A
Citation: Ji. Nezu et al., Primary systemic carnitine deficiency is caused by mutations in a gene encoding sodium ion-dependent carnitine transporter, NAT GENET, 21(1), 1999, pp. 91-94
Authors:
Tanabe, S
Shimohigashi, Y
Nakayama, Y
Makino, T
Fujita, T
Nose, T
Tsujimoto, G
Yokokura, T
Naito, M
Tsuruo, T
Terasaki, T
Citation: S. Tanabe et al., In vivo and in vitro evidence of blood-brain barrier transport of a novel cationic arginine-vasopressin fragment 4-9 analog, J PHARM EXP, 290(2), 1999, pp. 561-568
Authors:
Koike, M
Awaji, T
Kataoka, M
Tsujimoto, G
Kartasova, T
Koike, A
Shiomi, T
Citation: M. Koike et al., Differential subcellular localization of DNA-dependent protein kinase components Ku and DNA-PKcs during mitosis, J CELL SCI, 112(22), 1999, pp. 4031-4039
Authors:
Xu, ZJ
Hirasawa, A
Shinoura, H
Tsujimoto, G
Citation: Zj. Xu et al., Interaction of the alpha(1B)-adrenergic receptor with gC1q-R, a multifunctional protein, J BIOL CHEM, 274(30), 1999, pp. 21149-21154
Authors:
Takei, R
Ikegaki, I
Shibata, K
Tsujimoto, G
Asano, T
Citation: R. Takei et al., Naftopidil, a novel alpha(1)-adrenoceptor antagonist, displays selective inhibition of canine prostatic pressure and high affinity binding to cloned human alpha(1)-adrenoceptors, JPN J PHARM, 79(4), 1999, pp. 447-454
Citation: M. Kataoka et al., Spatial and temporal regulation of protein expression by bldA within a Streptomyces lividans colony, FEBS LETTER, 462(3), 1999, pp. 425-429
Citation: Y. Takei et al., Identification of the sequence responsible for the nuclear localization ofhuman Cdc6, FEBS LETTER, 447(2-3), 1999, pp. 292-296
Authors:
Ohmi, K
Shinoura, H
Nakayama, Y
Goda, N
Tsujimoto, G
Citation: K. Ohmi et al., Characterization of alpha(1)-adrenoceptors expressed in a novel vascular smooth muscle cell line cloned from p53 knockout mice, P53LMAC01 (AC01) cells, BR J PHARM, 127(3), 1999, pp. 756-762
Authors:
Moriyama, N
Yamaguchi, T
Takeuchi, T
Sakamoto, E
Ueki, T
Tsujimoto, G
Kawabe, K
Citation: N. Moriyama et al., Semiquantitative evaluation of alpha(1a)-adrenoceptor subtype mRNA in human hypertrophied and non-hypertrophied prostates: Regional comparison, LIFE SCI, 64(3), 1998, pp. 201-210
Authors:
Yamamura, Y
Nakamura, S
Itoh, S
Hirano, T
Onogawa, T
Yamashita, T
Yamada, Y
Tsujimae, K
Aoyama, M
Kotosai, K
Ogawa, H
Yamashita, H
Kondo, K
Tominaga, M
Tsujimoto, G
Mori, T
Citation: Y. Yamamura et al., OPC-41061, a highly potent human vasopressin V-2-receptor antagonist: Pharmacological profile and aquaretic effect by single and multiple oral dosingin rats, J PHARM EXP, 287(3), 1998, pp. 860-867